Indefinite Delivery Contract 36E79720D0040
Award Date
10/15/20
Last Date to Order
10/14/22
Federal Agency
National Acquisition Center
Awardee
Baxter Healthcare Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Acquisition Center of the Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company, for the supply of Bortezomib vials. The $2,237,072.60 contract covers a one-year base period from March 11, 2023, to March 10, 2024, with four one-year option periods. The contract is intended to provide an uninterrupted source of Bortezomib, a cancer treatment drug, to the VA, Department of Defense,...
The National Acquisition Center, a civilian federal agency, has awarded an indefinite delivery contract to Sandoz Inc., a global leader in generic pharmaceuticals, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The $766,987.10 contract has a base year plus four one-year option periods, and authorizes the ordering of products from Sandoz Inc.'s commercial catalogs to meet the medication needs of veterans, active duty military...
The Department of Veterans Affairs National Acquisition Center has awarded a single-award Indefinite Delivery Contract (IDC) to Organon LLC for Infliximab Injection 100 mg/vial. The $119,538,562.32 contract has a base period of one year and four one-year option periods, running from September 1, 2023 through August 31, 2025. This IDC will provide an uninterrupted supply of the pharmaceutical product to the VA, Bureau of Prisons, and Indian Health Service through the VA's Pharmaceutical Prime...
This federal contract IDV award to Baxter Healthcare Corporation, doing business as Baxter Health Systems, is for the delivery of intravenous (IV) solutions and administration sets to the U.S. Department of Veterans Affairs (VA) and Indian Health Service. The $65 million IDIQ contract through the VA National Acquisition Center runs from 2022 to 2024. Baxter also holds a maintenance and service IDIQ with VA VISN 12 and a $3 million blanket purchase agreement with Indian Health Services to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 (VA-VHA) awarded a single award Indefinite Delivery Contract to Baxter Healthcare Corporation for continuous ambulatory peritoneal dialysis (CAPD) supplies and equipment. Two firm fixed price delivery orders were issued against the IDV totaling $1,043,050 for performance at Baxter's facilities in Riverwoods, Illinois and St. Louis, Missouri from July 2020 through June 2025. The original...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Coherus Biosciences, Inc. for the procurement of Pegfilgrastim, a pharmaceutical product. The contract is valued at a ceiling of $27,626,788.30 and has a period of performance from April 11, 2025 to April 10, 2026, with four one-year option periods. The purpose of this contract is to provide an uninterrupted supply of Pegfilgrastim to the VA, including its...
The federal contract IDV award is a single award Indefinite Delivery Contract between the Department of Veterans Affairs (VA) National Acquisition Center and Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications through the VA and Department of Defense (DoD) pharmaceutical prime vendor programs. The contract has a base period of performance from May 30, 2021 to May 29, 2022 with four one-year option periods, and a ceiling value of $9,803,319.55. The...
The Department of Veterans Affairs (VA) National Acquisition Center awarded an Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc. to provide Dofetilide Capsules. This single-award contract has a base year of October 1, 2024 to September 30, 2025, with four one-year option periods, for a total potential period of performance through October 2, 2024. The contract has a ceiling value of $4,621,195.27 and will serve the VA, Department of Defense (DoD), Bureau of Prisons (BOP),...
The Department of Veterans Affairs (VA) National Acquisition Center has awarded Organon LLC a single-award Indefinite Delivery Contract (IDC) valued at $325,063,436.44 to provide Adalimumab pen and syringe kits. The contract has a base year of March 9, 2024 to March 8, 2025, with four one-year option periods, for a total potential period of performance through March 8, 2026. The IDC will support the VA's Pharmaceutical Prime Vendor program, as well as provide Adalimumab products to the Bureau of...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), to Pfizer Inc. as the prime contractor. The single-award IDC has a ceiling value of $74,038,216.80 and a base ordering period from September 15, 2025 to September 14, 2026, with four one-year option periods. The contract is for the procurement of Rituximab and its biosimilar products to support multiple federal healthcare agencies,...